Single-use technologies are widely used in the biotherapeutic market to reduce risk and improve operational efficiencies.
Scope of the Report:
Rising awareness about therapeutic applications of biotherapeutics is a key driver for the global single-use technologies market.
The global Single-Use Technologies for the Biologic market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Single-Use Technologies for the Biologic.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Single-Use Technologies for the Biologic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Single-Use Technologies for the Biologic market by product type and applications/end industries.
Market Segment by Companies, this report covers
Thermo Fisher Scientific
Applikon Biotechnology
GE Healthcare
Pall
BioPure Technology
Sartorius
Novasep
W. L. Gore and Associates
EMD Millipore
DowDuPont
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Membrane Adsorber
Bioreactors
Disposable Mixing Systems
Tangential Flow Filtration
Tubing and Connectors
Depth Filtration
Buffer Containers
Waste Containers
Market Segment by Applications, can be divided into
Monoclonal Antibodies
Vaccines
Gene Therapy
Recombinant Proteins
Blood Derivatives
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Single-Use Technologies for the Biologic Market Overview
1.1 Product Overview and Scope of Single-Use Technologies for the Biologic
1.2 Classification of Single-Use Technologies for the Biologic by Types
1.2.1 Global Single-Use Technologies for the Biologic Revenue Comparison by Types (2017-2023)
1.2.2 Global Single-Use Technologies for the Biologic Revenue Market Share by Types in 2017
1.2.3 Membrane Adsorber
1.2.4 Bioreactors
1.2.5 Disposable Mixing Systems
1.2.6 Tangential Flow Filtration
1.2.7 Tubing and Connectors
1.2.8 Depth Filtration
1.2.9 Buffer Containers
1.2.10 Waste Containers
1.3 Global Single-Use Technologies for the Biologic Market by Application
1.3.1 Global Single-Use Technologies for the Biologic Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Monoclonal Antibodies
1.3.3 Vaccines
1.3.4 Gene Therapy
1.3.5 Recombinant Proteins
1.3.6 Blood Derivatives
1.4 Global Single-Use Technologies for the Biologic Market by Regions
1.4.1 Global Single-Use Technologies for the Biologic Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Single-Use Technologies for the Biologic Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Single-Use Technologies for the Biologic Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Single-Use Technologies for the Biologic Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Single-Use Technologies for the Biologic Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Single-Use Technologies for the Biologic Status and Prospect (2013-2023)
1.5 Global Market Size of Single-Use Technologies for the Biologic (2013-2023)
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Business Overview
2.1.2 Single-Use Technologies for the Biologic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Thermo Fisher Scientific Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2016-2017)
2.2 Applikon Biotechnology
2.2.1 Business Overview
2.2.2 Single-Use Technologies for the Biologic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Applikon Biotechnology Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2016-2017)
2.3 GE Healthcare
2.3.1 Business Overview
2.3.2 Single-Use Technologies for the Biologic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GE Healthcare Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pall
2.4.1 Business Overview
2.4.2 Single-Use Technologies for the Biologic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pall Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2016-2017)
2.5 BioPure Technology
2.5.1 Business Overview
2.5.2 Single-Use Technologies for the Biologic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BioPure Technology Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sartorius
2.6.1 Business Overview
2.6.2 Single-Use Technologies for the Biologic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sartorius Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novasep
2.7.1 Business Overview
2.7.2 Single-Use Technologies for the Biologic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novasep Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2016-2017)
2.8 W. L. Gore and Associates
2.8.1 Business Overview
2.8.2 Single-Use Technologies for the Biologic Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 W. L. Gore and Associates Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2016-2017)
2.9 EMD Millipore
2.9.1 Business Overview
2.9.2 Single-Use Technologies for the Biologic Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 EMD Millipore Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2016-2017)
2.10 DowDuPont
2.10.1 Business Overview
2.10.2 Single-Use Technologies for the Biologic Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 DowDuPont Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2016-2017)
3 Global Single-Use Technologies for the Biologic Market Competition, by Players
3.1 Global Single-Use Technologies for the Biologic Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Single-Use Technologies for the Biologic Players Market Share
3.2.2 Top 10 Single-Use Technologies for the Biologic Players Market Share
3.3 Market Competition Trend
4 Global Single-Use Technologies for the Biologic Market Size by Regions
4.1 Global Single-Use Technologies for the Biologic Revenue and Market Share by Regions
4.2 North America Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
4.3 Europe Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
4.5 South America Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
5 North America Single-Use Technologies for the Biologic Revenue by Countries
5.1 North America Single-Use Technologies for the Biologic Revenue by Countries (2013-2018)
5.2 USA Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
5.3 Canada Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
5.4 Mexico Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
6 Europe Single-Use Technologies for the Biologic Revenue by Countries
6.1 Europe Single-Use Technologies for the Biologic Revenue by Countries (2013-2018)
6.2 Germany Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
6.3 UK Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
6.4 France Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
6.5 Russia Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
6.6 Italy Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Single-Use Technologies for the Biologic Revenue by Countries
7.1 Asia-Pacific Single-Use Technologies for the Biologic Revenue by Countries (2013-2018)
7.2 China Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
7.3 Japan Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
7.4 Korea Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
7.5 India Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
8 South America Single-Use Technologies for the Biologic Revenue by Countries
8.1 South America Single-Use Technologies for the Biologic Revenue by Countries (2013-2018)
8.2 Brazil Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
8.3 Argentina Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
8.4 Colombia Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Single-Use Technologies for the Biologic by Countries
9.1 Middle East and Africa Single-Use Technologies for the Biologic Revenue by Countries (2013-2018)
9.2 Saudi Arabia Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
9.3 UAE Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
9.4 Egypt Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
9.5 Nigeria Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
9.6 South Africa Single-Use Technologies for the Biologic Revenue and Growth Rate (2013-2018)
10 Global Single-Use Technologies for the Biologic Market Segment by Type
10.1 Global Single-Use Technologies for the Biologic Revenue and Market Share by Type (2013-2018)
10.2 Global Single-Use Technologies for the Biologic Market Forecast by Type (2018-2023)
10.3 Membrane Adsorber Revenue Growth Rate (2013-2023)
10.4 Bioreactors Revenue Growth Rate (2013-2023)
10.5 Disposable Mixing Systems Revenue Growth Rate (2013-2023)
10.6 Tangential Flow Filtration Revenue Growth Rate (2013-2023)
10.7 Tubing and Connectors Revenue Growth Rate (2013-2023)
10.8 Depth Filtration Revenue Growth Rate (2013-2023)
10.9 Buffer Containers Revenue Growth Rate (2013-2023)
10.10 Waste Containers Revenue Growth Rate (2013-2023)
11 Global Single-Use Technologies for the Biologic Market Segment by Application
11.1 Global Single-Use Technologies for the Biologic Revenue Market Share by Application (2013-2018)
11.2 Single-Use Technologies for the Biologic Market Forecast by Application (2018-2023)
11.3 Monoclonal Antibodies Revenue Growth (2013-2018)
11.4 Vaccines Revenue Growth (2013-2018)
11.5 Gene Therapy Revenue Growth (2013-2018)
11.6 Recombinant Proteins Revenue Growth (2013-2018)
11.7 Blood Derivatives Revenue Growth (2013-2018)
12 Global Single-Use Technologies for the Biologic Market Size Forecast (2018-2023)
12.1 Global Single-Use Technologies for the Biologic Market Size Forecast (2018-2023)
12.2 Global Single-Use Technologies for the Biologic Market Forecast by Regions (2018-2023)
12.3 North America Single-Use Technologies for the Biologic Revenue Market Forecast (2018-2023)
12.4 Europe Single-Use Technologies for the Biologic Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Single-Use Technologies for the Biologic Revenue Market Forecast (2018-2023)
12.6 South America Single-Use Technologies for the Biologic Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Single-Use Technologies for the Biologic Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Single-Use Technologies for the Biologic Picture
Table Product Specifications of Single-Use Technologies for the Biologic
Table Global Single-Use Technologies for th